Prime Health vs Peter MD: Compare GLP-1 Programs & Pricing
Side-by-side Prime Health and Peter MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Prime Health and Peter MD are two telehealth providers frequently chosen for GLP-1–based weight-management and metabolic care. This article compares core items — pricing, promos, clinical workflow, medication quality and safety — to help you determine which service best fits your needs while respecting telehealth and FDA-aligned care pathways.
Visit Prime Health
Explore Peter MD
Prime Health vs Peter MD: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Prime Health | $179.00 | $279.00 | $120 off first month (Code: BWLM2025) | No |
| Peter MD |
Prime Health vs Peter MD: Pricing Comparison
Prime Health lists semaglutide starting at $179.00 and tirzepatide at $279.00. Peter MD does not publish starting retail prices in the same way on the pages reviewed here, so prospective patients should check Peter MD’s site or contact support for current rates and any promotional offers. Prime Health is also advertising a first-month promo: “$120 off first month” using code BWLM2025.
Membership requirements differ across telehealth providers — Prime Health does not require a recurring membership for access to these medications. Peter MD’s membership or program fee structure was not available in the material provided. Be sure to verify whether a program fee, subscription, or minimum commitment applies before enrolling since total cost of care includes clinical follow-up and shipping.
Prime Health vs Peter MD: Medical Process & Accessibility
Both providers operate via telehealth evaluations and employ licensed clinicians to review medical history, current medications and risk factors before prescribing. An initial virtual intake, medical review, and clinician clearance are standard; clinicians determine appropriateness based on FDA-approved indications and individual patient safety considerations.
Important: some GLP-1 medications have FDA-approved labeling for type 2 diabetes and/or chronic weight management (for example, branded semaglutide formulations). Telehealth prescribers may offer compounded or alternative formulations; clinicians will not prescribe if a treatment is unsafe or contraindicated. Always disclose medical history (including pregnancy plans, pancreatitis, personal/family medullary thyroid carcinoma or MEN2) during evaluation.
Prime Health vs Peter MD: Medication Quality & Safety
Medications can be sourced from licensed U.S. pharmacies; many telehealth programs use accredited compounding pharmacies when branded products are not dispensed. Compounded peptides and GLP-1 analogs differ from FDA-branded products in formulation and approval status. Providers should make clear whether a product is a branded, off-label or compounded preparation.
Prime Health vs Peter MD: Clinical Oversight & Support
Prime Health emphasizes rapid onboarding and affordability with clinician supervision for prescriptions and routine check-ins. Peter MD highlights structured follow-up and dose adjustments with clinical feedback. Both models aim to combine remote convenience with medical oversight; quality differs by clinician availability, scope of follow-up and platform tools (labs, messaging, refill policies).
Prime Health vs Peter MD: Final Verdict
Choose Prime Health if your priority is clearly displayed pricing and low advertised start rates plus a first-month promo. Choose Peter MD if you prefer a provider known for structured clinical follow-up and personalized dose management, but verify pricing and membership details directly. In all cases, ensure a licensed clinician reviews your health history and that therapies are prescribed consistent with safety guidelines.
Join Prime Health
Get Started with Peter MD
Disclaimer
This article is informational and not medical advice. Prescription of GLP-1 medications requires individual clinical judgment; a licensed clinician should evaluate your suitability. Branded GLP-1 agents have specific FDA indications — clinicians will prescribe only when appropriate. ExploreProviders and affiliated sites may receive referral compensation; always consult a licensed healthcare professional before starting therapy.